FindTrial
Sign In

Development of surgical site infection prevention with platelet rich plasma

Development of Surgical site infection prevention method with platelet rich plasma (PRP) - SSI prevention with PRP

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000039546
Enrollment
10
Registered
2020-02-21
Start date
2020-02-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infection

Interventions

None listed

Sponsors

Hiroshima University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Healthy male subjects at age between 20 and 60 upon consent 2.Subjects who can come to collect blood in the morning of the day to conduct the study. 3.Subjects who gives written agreement to the informed consent.

Exclusion criteria

Exclusion criteria: Volunteer who comes under any of below conditions are excluded from the study. 1.Subject who has smoking habits 2.Subject who has any blood disease (cancer, anemia, etc) or blood born transmitted disease (hepatitis virus infection) 3.Subject who was prescribed with anti-coagulant (warfarin) or anti-platelet (aspirin) drug 4.Subject who has allergy to alcohol 5.Subject who is rejected by researcher

Design outcomes

Primary

MeasureTime frame
To quantify the anti-bacterial activity to bacteria, which is frequently isolated in SSI and DSWI cases in Japan.—

Countries

Japan

Contacts

Public ContactHiroko Tanaka

Hiroshima University Hospital Department of Infectious Diseases

kansen@hiroshima-u.ac.jp082-257-1613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026